Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) Q1 2026 Earnings Call Transcript

Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) Q1 2026 Earnings Call Transcript May 13, 2026

Insight Molecular Diagnostics Inc. beats earnings expectations. Reported EPS is $-0.12, expectations were $-0.26152.

Gabrielle Woody: Welcome, everyone, and thank you for joining us to discuss Insight Molecular Diagnostics’ First Quarter 2026 Results. If you have not seen today’s shareholder letter, please visit Insight Molecular Diagnostics Investor Relations page at investors.imgxinc.com. Today’s...